The University of Alberta Hospital (UAH) is one of only a few centers in Canada that perform living donor liver transplantation, a surgical procedure developed in the late 1980s that expands the organ donor pool. About 80 liver transplants are done a year in Alberta, 10 of those being living-donor.
All potential liver transplant donors are assessed based on considerations such as the size and composition of the liver and vascular and bile duct anatomy. Thanks to a review paper done at the University of Alberta radiologists at the University of Alberta Hospital are now using CT (Computed Tomography) imaging for living-donor liver transplantation. This technique shows relevant liver anatomy and, in particular, enhances high resolution imaging of the vital bile duct anatomy.
“CT scans provide a clear image of the important ducts we need to see,” said Dr. Gavin Low, a clinical fellow in the University of Alberta’s Faculty of Medicine and Dentistry and author of a recent study describing this process. In the past radiologists have only been using an MRI to scan possible donors for bile duct anatomy, but Low said that, “By using CT imaging the results are much more accurate and reliable for the surgeons.”
Right now possible donors are screened with both MRI and CT scans but Low says the hope is to one day only use CT imaging; adding, “All-in-one imaging will speed up the process and make living-donor evaluation more convenient for potential donors.”
As many as four patients are evaluated by CT imaging every month.
Source: University of Alberta
Related stories:
Studies test new approaches to islet transplantation
Researchers from 11 medical centers in the United States, Canada, Sweden, and Norway have begun testing new approaches to transplanting clusters of insulin-producing islets in adults with difficult-to-control type 1 diabetes. The clinical studies, funded by the National Institutes of Health (NIH), will determine whether changes to current methods of islet transplantation lead to improved, long-lasting control of blood glucose with fewer side effects.
Some light shed on blood sugar production
A University of Alberta diabetes researcher has collaborated on a body of diabetes research that has unravelled the signalling pathway mystery that controls the production of blood sugar.
Researchers report breakthrough in lowering bad cholesterol, fatty acid levels
There is “heartening” news out of the University of Alberta for those who may have overindulged during the recent holidays.
Menstruation proves more than a curse
The cells which thicken the womb wall during a woman's menstrual cycle contain a newly discovered type of stem cell, and could be used in the treatment of damaged and/or old tissue, according to research published today in the online open access publication,
Journal of Translational Medicine.
Researchers isolate new risk marker for overweight children
A study of 40 overweight children in Edmonton has revealed they all share something in common aside from being heavy: each one of them has high levels of apoB48, a structural protein found in intestinal cholesterol.
High insulin levels impair intestinal metabolic function
Nutritional scientists at the University of Alberta are the first to establish a connection between high insulin levels and dysfunction of intestinal lipid metabolism in an animal model. They believe this finding supports their contention that impaired intestinal metabolic function plays a critical role in the development of cardiovascular disease.
Elusive protein protects malaria parasite from heme
Researchers at the Virginia Bioinformatics Institute at Virginia Tech have identified Heme Detoxification Protein, a unique protein encoded in the malaria genome that represents a potential target for developing new malaria drugs.
Blocked brain enzyme decreases appetite and promotes weight loss
Imagine being able to tone down appetite and promote weight loss, while improving the body’s ability to handle blood sugar levels. That’s just what Tony Means, PhD, and his team at the Duke University Medical Center were able to do when they blocked a brain enzyme, CaMKK2, in mice.